tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kelly Shi, 18 are a BUY (94.74%), 1 are a HOLD (5.26%).
Analyst Kelly Shi, currently employed at JEFFERIES, carries an average stock price target met ratio of 57.14% that have a potential upside of 28.84% achieved within 222 days.
Kelly Shi’s has documented 38 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PTCT, PTC Therapeutics at 20-May-2024.
Analyst best performing recommendations are on MLTX (MOONLAKE IMMUNOTHERAPEUTICS).
The best stock recommendation documented was for MLTX (MOONLAKE IMMUNOTHERAPEUTICS) at 6/26/2023. The price target of $58 was fulfilled within 22 days with a profit of $12.05 (26.22%) receiving and performance score of 11.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$0.5
$0.5 (0.00%)
$0.5
1 years 7 months 15 days ago
(03-Apr-2023)
1/4 (25%)
$0.36 (257.14%)
2
Hold
$0.15
$0.15 (0.00%)
$2
1 years 10 months 7 days ago
(11-Jan-2023)
1/4 (25%)
$-0.01 (-6.25%)
8
Buy
$19
$18.86 (13471.43%)
$19
2 years 10 months 15 days ago
(03-Jan-2022)
0/5 (0%)
$14.39 (153.53%)
Sell
$21
3 years 2 months 9 days ago
(09-Sep-2021)
2/2 (100%)
$0.83 (4.65%)
18
Buy
$30
$29.99 (299900.00%)
$30
3 years 2 months 25 days ago
(24-Aug-2021)
0/2 (0%)
$11.69 (64.34%)
What Year was the first public recommendation made by Kelly Shi?
